Corporate Banner
Satellite Banner
Technology Networks Header
Friday, September 19, 2014
Technology Networks
 
Register | Sign in
Home Page>Events

  Events

September 2014
Scientific News
Blood Test To Diagnose Depression
Test identifies nine blood markers tied to depression; predicts who will benefit from therapy.
Study Aims to Develop Breath Test for COPD
A new clinical iniative, lead by NYU Langone Medical Center, aims to determine a breath test’s effectiveness to identify volatile organic compounds (VOCs) in human breath that are biomarkers of chronic obstructive pulmonary disease (COPD).
More People Testing Positive for Chikungunya Virus in the U.S.
Clinical testing volume and positivity rate both grew after the first case of the infectious disease spread to Western Hemisphere this year.
Clinical Utility of Myriad myPath(TM) Melanoma Test Demonstrated
Test reduced indeterminate cases by 76 percent and changed treatment in 35 percent of cases.
Sequencing Identifies Gene Variant Responsible for Lupus
Research demonstrates it is feasible to identify the individual causes of lupus in patients by using DNA sequencing, allowing doctors to target specific treatments to individual patients.
Array Technology Could Screen for Emerging Viral Diseases
A microbe detection array technology could provide a new rapid method for public health authorities to conduct surveillance for emerging viral diseases.
Self-assembling Nanoparticle Could Improve MRI Scanning for Cancer Diagnosis
Scientists have designed the nanoparticle that targets tumours, to help doctors diagnose cancer earlier.
Researchers Invent Nanotech Microchip to Diagnose Type-1 Diabetes
The cheap, portable, microchip-based test could speed up diagnosis and enable studies of how the disease develops.
Significant Step Towards Blood Test for Alzheimer's
Scientists have identified a set of 10 proteins in the blood which can predict the onset of Alzheimer’s, marking a significant step towards developing a blood test for the disease.
Mass Spec Predicts Improved Response to Anti-HER2 Therapy in Breast Cancer
Immunohistochemistry is the standard technique for detecting HER2 protein expression, it does not provide absolute quantification of this receptor and is prone to false-positives.
26th European Congress of Pathology
30 Aug 2014 - 03 Sep 2014

26th European Congress of Pathology
More information
01 Sep 2014 - 02 Sep 2014
Odinsgatan 28, 411 03 Göteborg, Sweden
2 days Hands-on qPCR
More information
04 Sep 2014 - 05 Sep 2014
Odinsgatan 28, 411 03 Göteborg, Sweden
2 days Experimental design and data analysis
More information
Biomarker Utilisation & Commercialisation
10 Sep 2014 - 11 Sep 2014
London, UK
Biomarker Utilisation & Commercialisation
More information
15 Sep 2014 - 16 Sep 2014
USA
e-Patients Connections 2014
More information
World IVD Congress(China)
16 Sep 2014 - 17 Sep 2014
Shanghai, China
World IVD Congress(China)
More information
17 Sep 2014 - 19 Sep 2014
San Diego, CA, USA
Medical Affairs Strategic Summit West
More information
17 Sep 2014 - 18 Sep 2014
London, UK
Advances in Clinical Technology
More information
Lab-on-a-Chip & Microarray World Congress
18 Sep 2014 - 19 Sep 2014
San Diego, CA, USA
Lab-on-a-Chip & Microarray World Congress
More information
<< 1 2 >>
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv